Today's Updates

Schizophrenia: Nighttime Light Tied to Metabolic Dysfunction
Published Date: 29 Jul 2026

Higher vs lower nighttime light exposure is associated with increased risk for obesity, hypertension, and dyslipidemia in patients with schizophrenia, a study suggests.

Read More
Transperineal Biopsy IDs Active Surveillance Candidates
Published Date: 29 Jul 2026

Transperineal 3D mapping biopsy may help select patients with low-risk prostate cancer who are most likely to fare well with active surveillance.

Read More
The Clues Hidden in Failed Prostate Cancer Trials
Published Date: 29 Jul 2026

Many experts consider prostate cancer one of immunotherapy’s biggest disappointments. But a handful of patients don’t fit that narrative, and researchers are starting to uncover why.

Read More

Latest News

Deep Dive: The Evolving GLP-1 Class Overview

The GLP-1 class now spans ten products across six indications. This clinical deep dive maps the 2026 roster to help clinicians select the right agent for established CVD, CKD, MASH, or OSA.

Revealing CKD: Early Detection Strategies to Reduce Cardiorenal Risk

Revealing CKD: Early Detection Strategies to Reduce Cardiorenal Risk

First-in-Class Drug Approved for IgA Nephropathy

It has not been established whether atacicept slows kidney function decline long-term, however

Ushering in a New Era of IgAN Care: Targeted Therapies and Evolving Guidelines

Ushering in a New Era of IgAN Care: Targeted Therapies and Evolving Guidelines

Navigating New Guidelines in IgA Nephropathy

Navigating New Guidelines in IgA Nephropathy

FDA Greenlights Novel Hypertension Pill for Tough-to-Treat Patients

Aldosterone synthase inhibitor baxdrostat indicated as add-on to other antihypertensives

CAR T-Cell Therapy Enabled Kidney Transplant in Highly Sensitized Patients

Strategy offers hope for hard-to-match patients

Trial Dims Prospects for Rivaroxaban's Cardiovascular Protection in Advanced CKD

Trial finds risk, but no benefit, with blood thinner

When Should Our Patients With Diabetes Eat?

Meal timing may be an underused tool

Measured GFR in Line With eGFR for Predicting CKD Outcomes

Combining creatinine and cystitis C offered best accuracy for estimated calculations

B-Cell Depleter Nabs Phase III Win in Autoimmune Kidney Disease

Obinutuzumab tops immunosuppressant tacrolimus for membranous nephropathy remissions

Video: Police Tussle With Diabetes Experts at ADA Meeting

Researchers told they could no longer attend the annual scientific sessions

Finerenone Also Slows Kidney Decline in Diabetes-Free Patients

Benefits were consistent across glomerular disease subtypes, too

Up to 40% of Diabetes Patients Achieved Normal HbA1c With Retatrutide

But its key advantage is in its weight reduction abilities

GLP-1, Amylin Analog Combo Cuts Blood Sugar, Weight in Diabetes Trials

Phase III trials back CagriSema in different type 2 diabetes populations

Monthly GLP-1 for Obesity Promising as More Manageable Alternative

Less frequent dosing could support better long-term adherence, says researcher

Latest News

Deep Dive: The Evolving GLP-1 Class Overview

The GLP-1 class now spans ten products across six indications. This clinical deep dive maps the 2026 roster to help clinicians select the right agent for established CVD, CKD, MASH, or OSA.

Revealing CKD: Early Detection Strategies to Reduce Cardiorenal Risk

Revealing CKD: Early Detection Strategies to Reduce Cardiorenal Risk

First-in-Class Drug Approved for IgA Nephropathy

It has not been established whether atacicept slows kidney function decline long-term, however

Ushering in a New Era of IgAN Care: Targeted Therapies and Evolving Guidelines

Ushering in a New Era of IgAN Care: Targeted Therapies and Evolving Guidelines

Navigating New Guidelines in IgA Nephropathy

Navigating New Guidelines in IgA Nephropathy

FDA Greenlights Novel Hypertension Pill for Tough-to-Treat Patients

Aldosterone synthase inhibitor baxdrostat indicated as add-on to other antihypertensives

CAR T-Cell Therapy Enabled Kidney Transplant in Highly Sensitized Patients

Strategy offers hope for hard-to-match patients

Trial Dims Prospects for Rivaroxaban's Cardiovascular Protection in Advanced CKD

Trial finds risk, but no benefit, with blood thinner

When Should Our Patients With Diabetes Eat?

Meal timing may be an underused tool

Measured GFR in Line With eGFR for Predicting CKD Outcomes

Combining creatinine and cystitis C offered best accuracy for estimated calculations

B-Cell Depleter Nabs Phase III Win in Autoimmune Kidney Disease

Obinutuzumab tops immunosuppressant tacrolimus for membranous nephropathy remissions

Video: Police Tussle With Diabetes Experts at ADA Meeting

Researchers told they could no longer attend the annual scientific sessions

Finerenone Also Slows Kidney Decline in Diabetes-Free Patients

Benefits were consistent across glomerular disease subtypes, too

Up to 40% of Diabetes Patients Achieved Normal HbA1c With Retatrutide

But its key advantage is in its weight reduction abilities

GLP-1, Amylin Analog Combo Cuts Blood Sugar, Weight in Diabetes Trials

Phase III trials back CagriSema in different type 2 diabetes populations

Monthly GLP-1 for Obesity Promising as More Manageable Alternative

Less frequent dosing could support better long-term adherence, says researcher

News All Time

APOL1 Gene and Focal Segmental Glomerulosclerosis

Genetic variants tied to increased risk are only found in those of African decent

Make the Diagnosis: Chest Pain, Dyspnea, Palpitations, and More: What’s Her Diagnosis?

A 45-year-old woman presented to the emergency department with complaints of chest pain, heart palpitations that developed earlier that day, and dyspnea that began 3 days prior and had progressed. Can you diagnose the patient?

Rewriting What We Know About Kidney Transplant Rejection

Rewriting What We Know About Kidney Transplant Rejection

First Oral Carbapenem Approved for Complicated UTIs

Tebipenem pivoxil proved noninferior to IV imipenem-cilastatin in hospitalized patients

How Did a Patient Survive a Decade With Metastatic RCC?

Surgery had beneficial role

360 Dead in Outbreak; McConnell Still Hospitalized? FDA Rejects Kidney Disease Drug

Health news and commentary gathered by MedPage Today staff

US FDA Declines to Approve Unicycive's Kidney Disease Drug

Unicycive Therapeutics said on Tuesday the U.S. drug regulator has declined to approve its drug to ⁠treat elevated phosphate levels in chronic kidney disease patients on...

The Chatbot Will See You Now: A Crisis in Trust?

When healthcare feels out of reach, Europe’s patients are turning to AI for answers — and sometimes for the confidence to medicate themselves.

Extended-Release Febuxostat Beats Standard Drug for Gout

A new 24-hour version of febuxostat lowers uric acid levels significantly better than the standard drug for patients with severe gout, though it may carry a higher risk of serious side effects.

Mineralys' Pill Cuts Blood Pressure in Kidney Disease Patients

Mineralys Therapeutics' experimental drug significantly reduced blood pressure in patients with chronic kidney disease, according to new data presented ⁠at a major European...

Project Aims for Awareness of APOL1-Mediated Kidney Disease

The EMBARK Awareness initiative is working to raise awareness of APOL-1 mediated kidney disease among high-risk populations and medical trainees.

APOL1-Mediated Kidney Disease: Managing Family Discussions, Testing, and Implications

APOL1-Mediated Kidney Disease: Managing Family Discussions, Testing, and Implications

Navigating APOL1 Genetic Testing: Counseling Patients and Their Families

Navigating APOL1 Genetic Testing: Counseling Patients and Their Families
HTTP error: 503HTTP error: 503HTTP error: 503

Recommended News For You

Potentially Novel Approach for Treating Advanced Colorectal Cancer with KRAS Mutations.

Study confirms safety and efficacy of higher-dose-per-day radiation for early-stage prostate cancer

Inside the Major Findings From the NHS-Galleri Trial

Don't Call It Cancer; Clues to 'Exceptional' Responses; More Predictions for 2025

Since 2000, the outlook for multiple myeloma has improved.

An understudied type of breast cancer poses a lurking threat

MRI Enhancement Predicts Breast Cancer in BRCA Carriers

Recommended Articles For You

The Potential of Amifostine in Cancer Treatment: A Revolutionary Breakthrough 

Contemporary Trends in Oncology and Patient Outcomes 

Unraveling the Mysteries of Coagulopathy: A Comprehensive Definition 

Clinical Methods in Hematology and Quality Improvement 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The Risk of Major Mortality is Associated with the Start of Opioids in Dementia.

2.

Poor agreement between diagnostic tests for breast cancer-related lymphedema

3.

Breast cancer-related fatigue: The benefits of adapted physical activity

4.

Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal

5.

To refute accusations that it failed to issue a cancer warning, Roundup's maker is asking lawmakers for assistance.

1.

Toripalimab + Nab-Paclitaxel in PD-L1+ TNBC: Phase 3 TORCHLIGHT Trial Results

2.

Exploring the Benefits of Teclistamab for Treating Advanced Cancer

3.

Molecular & Genetic Oncology: Emerging Frontiers in 2025

4.

Understanding Pancreatic Cancer: Symptoms, Causes and Risk Factors 

5.

Everything You Need To Know About Splenic Infarction – Symptoms, Treatments, And Prevention

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC

2.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

3.

From Relapse to Remission : Chasing the Invisible and Redefining Long-Term Survival in Adult R/R B-Cell ALL

4.

Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective

5.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot